Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease

被引:6
作者
Zahn, R
Beeck, H
Winkelmann, BR
Seidl, K
Schneider, S
Hellstern, P
Senges, J
机构
[1] Herzzentrum Ludwigshafen, Dept Cardiol, D-67063 Ludwigshafen, Germany
[2] Herzzentrum Ludwigshafen, Dept Haemostasis, Ludwigshafen, Germany
关键词
coronary heart disease; risk factors; haemostatic factors; activated protein C resistance;
D O I
10.1097/00001721-200203000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of haemostatic factors for arterial thrombosis, especially the prevalence of activated protein C (APC) resistance in patients with coronary artery disease (CAD), is controversial. Between November 1996 and August 1997, 665 patients were analyzed. Diagnosis of CAD was confirmed by coronary angiography, exclusion of CAD was accepted in the presence of negative stress testing or a negative coronary angiography. CAD was present in 370 (56%) and excluded in 295 (44%) patients. Patients with CAD were older (64 +/- 9.2 versus 57.7 +/- 16 years; P less than or equal to 0.001), more often male [74.1 versus 48.5%; odds ratio (OR) = 3.0, 95% confidence interval (CI) = 2.2-4.2] and had a higher body mass index (27.2 +/- 3.6 versus 26 +/- 4.3; P less than or equal to 0.001). Most conventional risk factors showed a higher prevalence in patients with CAD. An APC ratio < 2.0 showed a tendency towards a higher prevalence in patients with CAD (10.5 versus 6.4%; OR = 1.7, 95% CI = 1.0-3.0). This difference was significant in men (11.7 versus 4.2%; OR = 3.0, 95% CI = 1.3-7.1), but not in women (7.3 versus 8.6%; OR = 0.8, 95% CI = 0.3-2.2). Multiple logistic regression analysis showed an independent association of the presence of CAD with age, male gender, current smoking, arterial hypertension, lipoprotein(a) levels and an APC ratio < 2.0 (OR = 2.87, 95% CI = 1.08-8.12). APC resistance with an APC ratio < 2.0 was the only haemostatic factor that was independently associated with the presence of CAD. This association was significant only for men. It may indicate a contribution of the APC resistance to the development of CAD, which has to be proven by the follow-up. Blood Coagul Fibrinolysis 13:81-87 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 39 条
[31]   Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women [J].
Ridker, PM ;
Buring, JE ;
Shih, J ;
Matias, M ;
Hennekens, CH .
CIRCULATION, 1998, 98 (08) :731-733
[32]   Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women [J].
Rosendaal, FR ;
Siscovick, DS ;
Schwartz, SM ;
Beverly, RK ;
Psaty, BM ;
Longstreth, WT ;
Raghunathan, TE ;
Koepsell, TD ;
Reitsma, PH .
BLOOD, 1997, 89 (08) :2817-2821
[33]   HEMOSTATIC FACTORS AND PREVALENT CORONARY HEART-DISEASE - THE FINRISK HEMOSTASIS STUDY [J].
SALOMAA, V ;
RASI, V ;
PEKKANEN, J ;
VAHTERA, E ;
JAUHIAINEN, M ;
VARTIAINEN, E ;
MYLLYLA, G ;
EHNHOLM, C .
EUROPEAN HEART JOURNAL, 1994, 15 (10) :1293-1299
[34]   Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study [J].
Smith, FB ;
Lee, AJ ;
Fowkes, FGR ;
Price, JF ;
Rumley, A ;
Lowe, GDO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3321-3325
[35]   RESISTANCE TO ACTIVATED PROTEIN-C AS A BASIS FOR VENOUS THROMBOSIS [J].
SVENSSON, PJ ;
DAHLBACK, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (08) :517-522
[36]   MODIFIED APC RESISTANCE ASSAY FOR PATIENTS ON ORAL ANTICOAGULANTS [J].
TROSSAERT, M ;
CONARD, J ;
HORELLOU, MH ;
SAMAMA, NM ;
IRELAND, H ;
BAYSTON, TA ;
LANE, DA .
LANCET, 1994, 344 (8938) :1709-1709
[37]   Reduced response to activated protein C is associated with increased risk for cerebrovascular disease [J].
vanderBom, JG ;
Bots, ML ;
Haverkate, F ;
Slagboom, PE ;
Meijer, P ;
deJong, PTVM ;
Hofman, A ;
Grobbee, DE ;
Kluft, C .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (04) :265-+
[38]  
YARNELL JWG, 1985, BRIT HEART J, V53, P483
[39]   LINKAGE BETWEEN INHERITED RESISTANCE TO ACTIVATED PROTEIN-C AND FACTOR-V GENE MUTATION IN VENOUS THROMBOSIS [J].
ZOLLER, B ;
DAHLBACK, B .
LANCET, 1994, 343 (8912) :1536-1538